Clinical Trial Update: This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of ZD6474 (vandetanib) in patients with metastatic breast cancer. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ZD6474 (vandetanib) (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Breast Neoplasms, Metastases, Neoplasm | Phase 2 | Status: COMPLETED